160 related articles for article (PubMed ID: 22363775)
1. Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus.
Tian D; Zhang W; He J; Liu Y; Song Z; Zhou Z; Zheng M; Hu Y
PLoS One; 2012; 7(2):e31965. PubMed ID: 22363775
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
[TBL] [Abstract][Full Text] [Related]
3. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
4. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
[TBL] [Abstract][Full Text] [Related]
5. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
7. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
8. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
Zhang R; Rong X; Pan W; Peng T
Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology.
Fang Y; Ye P; Wang X; Xu X; Reisen W
J Virol Methods; 2011 May; 173(2):251-8. PubMed ID: 21349291
[TBL] [Abstract][Full Text] [Related]
10. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers JA; Van De Velde LA; Allison KJ; Branum KC; Webby RJ; Flynn PM
Clin Infect Dis; 2010 Jun; 50(11):1487-92. PubMed ID: 20415539
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
Klimova RR; Masalova OV; Burtseva EI; Chichev EV; Lesnova EI; Oskerko TA; Mukasheva EA; Rudneva IA; Lvov DK; Kushch AA
Vopr Virusol; 2011; 56(3):15-20. PubMed ID: 21786621
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency.
Wagner R; Pfleiderer M
Expert Rev Vaccines; 2012 Aug; 11(8):881-3. PubMed ID: 23002967
[No Abstract] [Full Text] [Related]
14. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.
Jegaskanda S; Job ER; Kramski M; Laurie K; Isitman G; de Rose R; Winnall WR; Stratov I; Brooks AG; Reading PC; Kent SJ
J Immunol; 2013 Feb; 190(4):1837-48. PubMed ID: 23319732
[TBL] [Abstract][Full Text] [Related]
16. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
17. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
Chen MI; Barr IG; Koh GC; Lee VJ; Lee CP; Shaw R; Lin C; Yap J; Cook AR; Tan BH; Loh JP; Barkham T; Chow VT; Lin RT; Leo YS
PLoS One; 2010 Aug; 5(8):e12474. PubMed ID: 20814575
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations.
Hong DK; Tremoulet AH; Burns JC; Lewis DB
Pediatr Infect Dis J; 2011 Jan; 30(1):67-9. PubMed ID: 20724956
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
Shen HH; Hou J; Zhao M; Xu J; Bai BK; Zhao J; Hu Y; Mao PY; Li BA; Mao YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
